Quarterly report · Q2
9993.TEDINET S100S0BM
Period2023-03-01 → 2023-08-31
Filed2023-10-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥50.6bn | 2023-03-01 → 2023-08-31 | Cons. | Net sales |
| Revenue | ¥99.5bn | 2022-03-01 → 2023-02-28 | Cons. | Net sales (5-year summary) |
| Revenue | ¥50.3bn | 2022-03-01 → 2022-08-31 | Cons. | Net sales |
| Operating income | ¥532m | 2023-03-01 → 2023-08-31 | Cons. | Operating income |
| Operating income | ¥683m | 2022-03-01 → 2022-08-31 | Cons. | Operating income |
| Ordinary income | ¥570m | 2023-03-01 → 2023-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥928m | 2022-03-01 → 2023-02-28 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥726m | 2022-03-01 → 2022-08-31 | Cons. | Ordinary income |
| Profit before tax | ¥587m | 2023-03-01 → 2023-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥663m | 2022-03-01 → 2022-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.0bn | 2023-03-01 → 2023-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥205m | 2022-03-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥433m | 2022-03-01 → 2022-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.0bn | 2023-03-01 → 2023-08-31 | Cons. | Profit loss |
| Net income | ¥433m | 2022-03-01 → 2022-08-31 | Cons. | Profit loss |
| Total assets | ¥56.0bn | at 2023-08-31 | Cons. | Assets |
| Total assets | ¥54.3bn | at 2023-02-28 | Cons. | Assets |
| Total assets | ¥50.5bn | at 2022-08-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥26.5bn | at 2023-08-31 | Cons. | Liabilities |
| Total liabilities | ¥25.6bn | at 2023-02-28 | Cons. | Liabilities |
| Net assets / equity | ¥29.5bn | at 2023-08-31 | Cons. | Net assets |
| Net assets / equity | ¥28.6bn | at 2023-02-28 | Cons. | Net assets |
| Net assets / equity | ¥29.2bn | at 2022-08-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.4bn | at 2023-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.4bn | at 2023-02-28 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.0bn | at 2023-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.9bn | at 2023-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.2bn | at 2022-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.7bn | at 2022-02-28d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥3.1bn | 2023-03-01 → 2023-08-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.9bn | 2022-03-01 → 2023-02-28 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.2bn | 2022-03-01 → 2022-08-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.8bn | 2023-03-01 → 2023-08-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥7.1bn | 2022-03-01 → 2023-02-28 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.3bn | 2022-03-01 → 2022-08-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥177m | 2023-03-01 → 2023-08-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥4.4bn | 2022-03-01 → 2023-02-28 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥483m | 2022-03-01 → 2022-08-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥95.13 | 2023-03-01 → 2023-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥32.32 | 2023-06-01 → 2023-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.9 | 2022-03-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.78 | 2022-03-01 → 2022-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.08 | 2022-06-01 → 2022-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥95.06 | 2023-03-01 → 2023-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥18.88 | 2022-03-01 → 2023-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥39.75 | 2022-03-01 → 2022-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 52.7% | at 2023-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.8% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.7% | at 2022-08-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-03-01 → 2023-08-31 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-03-01 → 2023-08-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-03-01 → 2023-08-31 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-03-01 → 2023-08-31 | ¥78m |
| Reconciling Itemsreconciling | revenue | 2023-03-01 → 2023-08-31 | −¥2.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-03-01 → 2023-08-31 | −¥2.5bn |
| Reconciling Itemsreconciling | segment profit | 2023-03-01 → 2023-08-31 | ¥5m |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue | 2023-03-01 → 2023-08-31 | ¥6.5bn |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue external | 2023-03-01 → 2023-08-31 | ¥6.5bn |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue intersegment | 2023-03-01 → 2023-08-31 | ¥0 |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | segment profit | 2023-03-01 → 2023-08-31 | ¥36m |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue | 2023-03-01 → 2023-08-31 | ¥44.5bn |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue external | 2023-03-01 → 2023-08-31 | ¥44.2bn |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue intersegment | 2023-03-01 → 2023-08-31 | ¥297m |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | segment profit | 2023-03-01 → 2023-08-31 | ¥412m |
| —segment total | revenue | 2023-03-01 → 2023-08-31 | ¥50.9bn |
| —segment total | revenue external | 2023-03-01 → 2023-08-31 | ¥50.6bn |
| —segment total | revenue intersegment | 2023-03-01 → 2023-08-31 | ¥297m |
| —segment total | segment profit | 2023-03-01 → 2023-08-31 | ¥449m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-03-01 → 2023-08-31 | ¥53.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-03-01 → 2023-08-31 | ¥50.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-03-01 → 2023-08-31 | ¥2.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-03-01 → 2023-08-31 | ¥527m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-03-01 → 2022-08-31 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-03-01 → 2022-08-31 | ¥3m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-03-01 → 2022-08-31 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-03-01 → 2022-08-31 | ¥56m |
| Reconciling Itemsreconciling | revenue | 2022-03-01 → 2022-08-31 | −¥2.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-03-01 → 2022-08-31 | −¥2.5bn |
| Reconciling Itemsreconciling | segment profit | 2022-03-01 → 2022-08-31 | −¥2m |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue | 2022-03-01 → 2022-08-31 | ¥6.5bn |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue external | 2022-03-01 → 2022-08-31 | ¥6.5bn |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue intersegment | 2022-03-01 → 2022-08-31 | ¥0 |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | segment profit | 2022-03-01 → 2022-08-31 | ¥49m |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue | 2022-03-01 → 2022-08-31 | ¥44.1bn |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue external | 2022-03-01 → 2022-08-31 | ¥43.8bn |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue intersegment | 2022-03-01 → 2022-08-31 | ¥299m |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | segment profit | 2022-03-01 → 2022-08-31 | ¥579m |
| —segment total | revenue | 2022-03-01 → 2022-08-31 | ¥50.6bn |
| —segment total | revenue external | 2022-03-01 → 2022-08-31 | ¥50.3bn |
| —segment total | revenue intersegment | 2022-03-01 → 2022-08-31 | ¥299m |
| —segment total | segment profit | 2022-03-01 → 2022-08-31 | ¥628m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-03-01 → 2022-08-31 | ¥52.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-03-01 → 2022-08-31 | ¥50.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-03-01 → 2022-08-31 | ¥2.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-03-01 → 2022-08-31 | ¥685m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 461
| Item | Context | Value | Unit |
|---|---|---|---|
| Capital stock | Prior1YearInstant | 2388000000 | JPY |
| Capital stock | CurrentQuarterInstant | 2388000000 | JPY |
| Capital surplus | Prior1YearInstant | 2211000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 2207000000 | JPY |
| Retained earnings | Prior1YearInstant | 24207000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 25086000000 | JPY |
| Treasury stock | Prior1YearInstant | -246000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -235000000 | JPY |
| Shareholders equity | Prior1YearInstant | 28561000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 29447000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 59000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 72000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 3000000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 2000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 62000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 74000000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 12000000 | JPY |
| Subscription rights to shares | CurrentQuarterInstant | 10000000 | JPY |
| Net assets | Prior1YearInstant | 28636000000 | JPY |
| Net assets | CurrentQuarterInstant | 29532000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 54259000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 56031000000 | JPY |
| Net sales | Prior1YTDDuration | 50309000000 | JPY |
| Net sales | CurrentYTDDuration | 50650000000 | JPY |
| Cost of sales | Prior1YTDDuration | 36612000000 | JPY |
| Cost of sales | CurrentYTDDuration | 36581000000 | JPY |
| Gross profit | Prior1YTDDuration | 13696000000 | JPY |
| Gross profit | CurrentYTDDuration | 14068000000 | JPY |
| Salaries sga | Prior1YTDDuration | 5418000000 | JPY |
| Salaries sga | CurrentYTDDuration | 5549000000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 296000000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 314000000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 50000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 62000000 | JPY |
| Depreciation sga | Prior1YTDDuration | 1309000000 | JPY |
| Depreciation sga | CurrentYTDDuration | 1480000000 | JPY |
| Other sga | Prior1YTDDuration | 5937000000 | JPY |
| Other sga | CurrentYTDDuration | 6128000000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 13012000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 13536000000 | JPY |
| Operating income | Prior1YTDDuration | 683000000 | JPY |
| Operating income | CurrentYTDDuration | 532000000 | JPY |
| Interest income noi | Prior1YTDDuration | 0 | JPY |
| Interest income noi | CurrentYTDDuration | 1000000 | JPY |
| Dividends income noi | Prior1YTDDuration | 7000000 | JPY |
| Dividends income noi | CurrentYTDDuration | 7000000 | JPY |
| Data providing fee noi | Prior1YTDDuration | 14000000 | JPY |
| Data providing fee noi | CurrentYTDDuration | 12000000 | JPY |
| Other noi | Prior1YTDDuration | 28000000 | JPY |
| Other noi | CurrentYTDDuration | 37000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |